Cymbalta is used to treat mental health disorders. The bottles were distributed nationwide, according to the FDA.

The FDA announced that more than 233,003 bottles of duloxetine were recalled on November 19 after finding the capsules contained high levels of N-nitroso-duloxetine. The chemical is an impurity ...

The recall affected over 233,003 30-count, 90-count and 1,000-count bottles of 60 mg Duloxetine capsules. The FDA does not suggest that patients stop taking Duloxetine immediately but instead talk ...

Rising Pharmaceuticals has voluntarily recalled over 233,000 bottles of Duloxetine in the US due ... and 1000-count bottles of 60mg capsules with specific lot numbers and expiration dates.

This was an open-label study conducted at 29 sites ... Study drug consisted of 2 capsules (30 mg of duloxetine in each capsule) taken once-daily. If necessary due to tolerability, the dose could ...

The results of the current investigation are based on the initial 12-week, open-label acute treatment phase of a randomized withdrawal study of duloxetine in the prevention of relapse of MDD.

The recalled products include the 30-count, 90-count and 1000-count bottles of 60 mg Duloxetine capsules. Newsweek has contacted Rising Pharmaceuticals for comment. N-nitroso compounds are ...